The Hims FTC lawsuit is still pending. Five more states joined on November 10, 2026. The Federal Trade Commission, the U.S. consumer protection agency, alleges problems with health data sharing, subscription charges and cancellation. Hims & Hers says it intends to defend the claims. Those allegations are not court findings.
Hims FTC lawsuit: what changed on November 10
As of November 12, 2026, the day this article was written, the FTC's case record lists the case as pending. Its latest listed filing is a first amended complaint, an updated document setting out the claims against Hims.
The FTC's November 10 announcement says Arizona, Florida, Nebraska, Ohio and Wisconsin joined Utah and California. California participates through Los Angeles County Counsel. These are co-plaintiffs: parties bringing the same lawsuit.
The case is in the U.S. District Court for the Northern District of California. The Commission voted 2–0 to authorize the amendment. That vote authorized a filing; the court decides the case.
What the FTC alleges, and what Hims says
The FTC and its original state partners announced the lawsuit on July 29, 2026. The allegations fall into three areas:
- Health privacy. The FTC alleges Hims “shared consumers’ sensitive health information with third-party advertising platforms” despite privacy assurances. The agency names Meta and Snap. The complaint alleges the sharing continued through at least May 2024. It says customer lists and website tracking tools disclosed information connected with people seeking particular treatments.
- Initial charges and renewals. The FTC alleges consumers were charged almost immediately after submitting an intake form, a health questionnaire. The agency says that timing wasn't clearly disclosed. The complaint says consumers lacked a chance to review and agree to the recommended treatment before being charged. It also alleges unclear refill charge dates.
- Cancellation. The FTC alleges customers faced obstacles when trying to stop subscriptions. Its July announcement describes cancellation options hidden behind other steps, even after online cancellation became available.
In its July 29 privacy statement, Hims says it separates information patients share with healthcare providers from marketing activity.
In its quarterly filing's legal note, Hims says it believes its legal arguments have merit and “intends to vigorously defend against the alleged claims.” It also says settlement talks with the FTC were unsuccessful. That filing predates the five states joining. After the states joined, a Hims & Hers spokesperson told Reuters: “We will vigorously defend ourselves against these follow-on claims, which rely on the same flawed allegations advanced in the government’s lawsuit.”
The amended complaint alleges violations of the FTC Act and state consumer-protection laws. It also alleges violations of the Restore Online Shoppers' Confidence Act, or ROSCA, the federal law on online recurring charges. The complaint describes requirements for clear terms and informed consent, meaning agreement after receiving clear information. It also describes a requirement for simple ways to stop recurring charges.
What this means for someone using Hims
The November 10 announcement concerns the lawsuit. It does not announce a customer refund program or a change to customers' treatment arrangements.
The complaint asks the court for an injunction, an order requiring conduct to stop, along with monetary relief and civil penalties. Those are requests, not awards. The filing does not establish that a particular customer is owed a particular refund.
For someone checking a subscription charge, the useful records are the terms accepted, the charge dates and any cancellation confirmation. The FTC's subscription guidance recommends keeping cancellation requests and related messages. It also explains how to dispute charges that were not authorized or continued after cancellation.
What the amendment does not settle
More states joining does not turn an allegation into a finding. An amended complaint remains one side's account of what happened and why it believes the law was broken.
The FTC's announcement expressly says the court will decide the case. The Commission's vote and the number of plaintiffs do not answer whether the allegations will be proved.
Hims' separate treatment-expansion plans are another subject. A company announcement about its offerings does not resolve this dispute over privacy, consent and subscriptions.
What happens next
Hims' quarterly filing says it filed a motion to dismiss on October 22, 2026. That is a request for the court to throw out the complaint. The filing lists a hearing on January 14, 2027.
That is the schedule the company reported before the amendment. A hearing date is not a promised decision date. The next useful updates are court orders and filings explaining how the amended complaint will proceed. The FTC's case record provides the public starting point for following those documents.
Why a privacy policy deserves specific questions
The FTC's health-app privacy checklist asks why information is collected, who receives it and what settings control sharing. Those questions are more useful than relying on the word “private” alone.
Research helps explain why. A 2019 JAMA Network Open study of apps for depression and quitting smoking found gaps between privacy disclosures and observed data sharing. A 2024 JAMA Network Open study of hospital websites found that many hospital websites either had no privacy policy or had one with limited information about outside recipients.
These studies examined apps and hospital websites. The Hims case rests on its own evidence. Their broader lesson is practical: a policy link alone does not answer what information leaves a service or who receives it.
What to check with any telehealth subscription
The FTC's subscription guidance describes a negative option as an arrangement where billing continues unless the customer takes action to stop it. For any telehealth service, four questions help make that arrangement clear:
- What triggers the first charge? Is it submitting the intake, a provider writing a prescription or accepting a treatment recommendation? The terms need to explain the point at which payment is authorized.
- How does renewal work? The billing date, refill date and delivery date may answer different questions. The useful details are when another charge occurs, whether the amount changes and the deadline for stopping it.
- How does cancellation work? The FTC recommends finding the cancellation instructions before signing up. After cancellation, it recommends keeping records and checking statements. If unwanted charges continue, its guidance explains contacting the card company to dispute them.
- What happens to health information? The privacy policy needs to explain collection and sharing, including advertising uses. The FTC's health-app checklist also points to settings that control what an app collects and shares. A question about medical care and a question about advertising data deserve separate answers.
Those are questions for every service, regardless of the name on the website. Clear answers help a person understand both the medical visit and the subscription agreement before committing.
Promise's own terms and privacy disclosures are at /terms, /privacy and /consumer-health-data.
At Promise, a licensed provider reviews every request, and not everyone qualifies.





